Compare Lustrum:Fuso Pharmaceutical Industries, Ltd.:4538

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Fuso Pharmaceutical Industries, Ltd. Go to web site 4538 Medicals 東証プライム March 1, 2000 1970.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Fuso Pharmaceutical Industries, Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Fuso Pharmaceutical Industries, Ltd. Balance Sheet 2024年3月期 Fuso Pharmaceutical Industries, Ltd. Balance Sheet 2023年3月期 Fuso Pharmaceutical Industries, Ltd. Balance Sheet 2022年3月期 Fuso Pharmaceutical Industries, Ltd. Balance Sheet 2021年3月期 Fuso Pharmaceutical Industries, Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
5,120down
(6.8%)down
8,014up
(11.1%)up
7,347up
(10.6%)up
7,074down
(10.1%)down
7,268
(10.5%)
Other Current AssetsHelp
(Percent)
39,827up
(52.5%)up
35,205up
(48.6%)up
32,440down
(46.8%)up
32,459up
(46.5%)up
30,743
(44.5%)
Tangible Fixed AssetsHelp
(Percent)
24,427up
(32.2%)down
23,763down
(32.8%)down
23,792down
(34.3%)down
24,638down
(35.3%)down
25,449
(36.8%)
Intangible Fixed AssetHelp
(Percent)
600up
(0.8%)up
329down
(0.5%)down
453up
(0.7%)up
323down
(0.5%)down
518
(0.7%)
Investments and OthersHelp
(Percent)
5,828up
(7.7%)up
5,155down
(7.1%)down
5,302down
(7.6%)down
5,382up
(7.7%)up
5,175
(7.5%)
Total AssetsHelp
(Percent)
75,802
(100%)
72,466
(100%)
69,334
(100%)
69,876
(100%)
69,153
(100%)
Total Current LiabilitiesHelp
(Percent)
32,120up
(42.4%)down
31,070up
(42.9%)up
29,044down
(41.9%)down
29,553up
(42.3%)up
28,606
(41.4%)
Total Long-term LiabilitiesHelp
(Percent)
7,021up
(9.3%)up
5,747down
(7.9%)down
5,758down
(8.3%)down
6,640down
(9.5%)down
8,245
(11.9%)
Shareholder's EquityHelp
(Percent)
36,661up
(48.4%)down
35,649up
(49.2%)down
34,532up
(49.8%)up
33,683up
(48.2%)up
32,302
(46.7%)
Total LiabilitiesHelp
(Percent)
75,802
(100%)
72,466
(100%)
69,334
(100%)
69,876
(100%)
69,153
(100%)

Fuso Pharmaceutical Industries, Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Fuso Pharmaceutical Industries, Ltd. Profit and Loss Account 2024年3月期 Fuso Pharmaceutical Industries, Ltd. Profit and Loss Account 2023年3月期 Fuso Pharmaceutical Industries, Ltd. Profit and Loss Account 2022年3月期 Fuso Pharmaceutical Industries, Ltd. Profit and Loss Account 2021年3月期 Fuso Pharmaceutical Industries, Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
55,407
(100%)
51,015
(100%)
49,632
(100%)
49,251
(100%)
46,901
(100%)
Total Sales
(Percent)
55,407
(100%)
51,015
(100%)
49,632
(100%)
49,251
(100%)
46,901
(100%)
Cost of SalesHelp
(Percent)
41,568up
(75.0%)up
37,275up
(73.1%)up
36,235up
(73.0%)up
35,142up
(71.4%)down
34,101
(72.7%)
Other Costs and RevenueHelp 12,461up
(22.5%)down
12,134up
(23.8%)down
11,913down
(24.0%)down
12,501up
(25.4%)down
12,093
(25.8%)
Total CostsHelp 54,029 49,409 48,148 47,643 46,194
Net RevenueHelp 13,839up
(25.0%)down
13,740up
(26.9%)down
13,397down
(27.0%)down
14,109up
(28.6%)up
12,800
(27.3%)
Earnings Before TaxHelp 1,767down
(3.2%)down
2,205up
(4.3%)up
1,911down
(3.9%)down
2,345up
(4.8%)up
1,042
(2.2%)
Net IncomeHelp 1,378down
(2.5%)down
1,606up
(3.1%)up
1,484down
(3.0%)down
1,608up
(3.3%)up
707
(1.5%)
当期純利益 1,378 1,606 1,484 1,608 707

Fuso Pharmaceutical Industries, Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Fuso Pharmaceutical Industries, Ltd. Cash Flow Statement 2024年3月期 Fuso Pharmaceutical Industries, Ltd. Cash Flow Statement 2023年3月期 Fuso Pharmaceutical Industries, Ltd. Cash Flow Statement 2022年3月期 Fuso Pharmaceutical Industries, Ltd. Cash Flow Statement 2021年3月期 Fuso Pharmaceutical Industries, Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
628down
(17.8%)down
2,853down
(100.0%)
3,497up
(100.0%)up
3,230down
(94.3%)down
5,726
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-3,536down
(-100.0%)down
-1,373up
(-48.1%)down
-1,553down
(-44.4%)down
-978up
(-28.6%)down
-1,485
(-25.9%)
Financing Cash FlowHelp
(Percent)
14up
(0.4%)up
-813up
(-28.5%)up
-1,671up
(-47.8%)up
-2,446down
(-71.4%)down
-1,799
(-31.4%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn -2,894down
(-81.8%)down
667up
(23.4%)up
273up
(7.8%)up
-194down
(-5.7%)down
2,442
(42.6%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Fuso Pharmaceutical Industries, Ltd.

Company where related level is highHelp

ONO PHARMACEUTICAL CO.,LTD.
Noile-Immune Biotech Inc.
Tsubota Laboratory Incorporated
SSP CO.,LTD.
Shionogi & Co.,Ltd.
Sumitomo Pharma Co., Ltd.
Astellas Pharma Inc.
BrightPath Biotherapeutics Co., Ltd.
Solasia Pharma K.K.
SanBio Company Limited